BIO-key International (BIO-key International) Cash-to-Debt : 0.11 (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. BIO-key International's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.11.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, BIO-key International couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for BIO-key International's Cash-to-Debt or its related term are showing as below:

BKYI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 5015.92 Max: No Debt
Current: 0.11

During the past 13 years, BIO-key International's highest Cash to Debt Ratio was No Debt. The lowest was 0.11. And the median was 5015.92.

BKYI's Cash-to-Debt is ranked worse than
85% of 1040 companies
in the Business Services industry
Industry Median: 0.985 vs BKYI: 0.11

BIO-key International Cash-to-Debt Historical Data

The historical data trend for BIO-key International's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

BIO-key International Cash-to-Debt Chart

BIO-key International Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

0.21

23.98

29.37

0.81

BIO-key International Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial															3.93	0.81	0.24	0.19	0.11

Competitive Comparison of BIO-key International's Cash-to-Debt

For the Security & Protection Services subindustry, BIO-key International's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIO-key International's Cash-to-Debt Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where BIO-key International's Cash-to-Debt falls into.

BIO-key International Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

BIO-key International's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.636	/	(2.876	+	0.365)
	=	0.81

BIO-key International's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.307	/	(2.519	+	0.222)
	=	0.11

BIO-key International (NAS:BKYI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

BIO-key International Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of BIO-key International's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-key International (BIO-key International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719

Website

https://www.bio-key.com

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Executives

Michael W Depasquale	director, officer: Co-Chief Executive Officer	1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan	officer: See Remarks	411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams	director	400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok	director	FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia	director	15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel	director	C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd	10 percent owner	5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin	director	FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis	director	3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao	director	SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush,	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch	officer: Chief Financial Officer	PO BOX 588, DUNSTABLE MA 01827
John Schoenherr	director	C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803